Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**FAM133CP** is a pseudogene, annotated as family with sequence similarity 133 member C, pseudogene, which refers to a genomic DNA sequence derived from a functional gene but lacking the capacity to encode a functional protein product, usually due to acquired mutations or truncations. Like other pseudogenes, FAM133CP does not produce a functional protein, and while it may be transcribed to RNA, it is not regarded as having a direct role as a therapeutic target, nor is it classified as a receptor, enzyme, transporter, or other druggable target class[1][3][5][9]. Pseudogenes may have subtle regulatory impacts, but currently FAM133CP is not recognized as a biomarker, disease driver, or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 133 member C, pseudogene (FAM133CP).